Our results also show that DNA binding by LexA derivatives that contain the LexA carboxy-terminal dimerization domain (amino acids 88 to 202) is considerably stronger than binding by fusions that lack it and that heterologous dimerization motifs cannot substitute for the LexA88202 function. These results suggest the need to reevaluate some previous studies of activation that employed LexA derivatives and modifications to recent experimental approaches that use LexA and GALA derivatives to detect and study protein-protein interactions.
Chimeric proteins that contain the DNA binding domains of the bacterial LexA repressor (10) or the yeast GAL4 activator (36) have facilitated the study of transcription regulation. We and others have used the ability to separate DNA binding from other functions to identify and map activation domains (10, 30, 34, 43, 61, 65) , ligand binding domains (20) , and domains that interact with other proteins (16, 49, 54) . LexA and GAL4 fusion proteins have also been used in screening procedures to identify activating motifs encoded by random bacterial open reading frames (50) , to characterize the strength of activation domains of proteins in various cell types (34, 58) , and to provide an internal standard in studies of site recognition by proteins that contain a second DNA binding domain (24, 33) . Very recently, we and others have employed LexA and GALA derivatives as "baits" in interactor trap assays to identify proteins that complex with known proteins (12, 23) .
LexA fusion proteins typically contain either the LexA amino-terminal DNA binding domain (LexA1l87) (10, 45, 69) or the complete protein (LexA1l202) which also includes a dimerization domain (4, 46, 69, 74) . Like many prokaryotic repressors (26, 32, 56, 66, 67, 72) , native LexA binds as a dimer to an operator that consists of two dyad symmetric half-sites (consensus sequence CTGTNNNNNNNNACAG) (5, 8, 77) . LexA derivatives are assayed for transcription activation by using reporter genes that carry one or more LexA operators upstream of the transcription start site of a gene such as lacZ (for yeast assays) or CAT (for mammalian cell assays) (10, 20) . For nonactivating LexA derivatives, DNA binding can be assayed by using a repression or blocking assay, in which binding of the LexA derivative to operator sequences located between an upstream activation site (UAS) and the transcription start site of a reporter gene diminishes its transcription (6, 9, 36 Here we present a study of variables that affect operator binding by several different LexA derivative proteins. In these experiments we compared operator binding by native LexA to binding by a number of LexA derivatives, in vivo by using a transcription activation assay, and in vitro by using a gel mobility shift assay. We then examined the binding of a number of LexA derivatives to a set of mutant operators. The results show that many fused moieties dramatically reduce the ability of the LexA moiety to bind the LexA operator. They also show that the LexA88-202 dimerization domain promotes high-affinity operator binding and that dimerization functions provided by heterologous proteins cannot substitute for this LexA88-202-specific function.
These results suggest the organization of native LexA is not strictly modular, in that the identity of one domain can affect the function of the other; in a simple model, a specific geometry of the LexA88202 dimerization domain encourages a spatially precise alignment of the LexAl-87 domains on operators. We discuss the relevance of these findings for the use of LexA fusion proteins to study transcription regulation and for their use in recently developed methods to detect and study protein-protein interactions.
MATERIALS AND METHODS
Fusion proteins. Many of the constructions used in this study have been previously described; all fusions and reporters are represented schematically in Fig. 1 . All constructions were made by using standard methods (1, 63 promoter. The 2,um plasmid directing synthesis of LexA1l87-GAL4 is RB1027 (10); the CEN ARS form is KL1027 (42) . The 2,um plasmid expressing LexAl17-Bicoid is SH32-3 (24) ; the CEN ARS form and the 2gum plasmid expressing LexA1l202-Bicoid (plasmid 14) are generous gifts of Steve Hanes (25) . The 2gm plasmid expressing LexA1_ 87-cFos is VR1001 (43) ; the CEN ARS form is KL1001 (42) .
The 2gm plasmid expressing LexAl-87-cMyc is VR1004 (43); the CEN-ARS form is KL1004 (42) . The 2,um plasmid expressing LexA1l7-GCN4 contains residues 12 to 281 of GCN4 (28) . The (41) is overexpressed sufficiently to titrate GAL80 (10, 49, 62) . The assay for repression was performed essentially as previously described (9) . Values were determined for eight independent colonies, in assays performed on two separate occasions. Cells were grown on the appropriate selective media containing glucose to saturated overnight cultures; these cultures were spun down, washed with water, and VOL. 12, 1992 Gel mobility shift assay. The general outline of the protocol is that described previously (18, 19 Binding reactions were done in 20 ,ul for 30 min at 30°C in a buffer composed of 4% glycerol, 1 mM EDTA (pH 8.0), 10 mM ,BME, 10 mM Tris-HCl (pH 7.6), 5 mM CaCl2, and 100 mM NaCl to which extract was added to give a final fusion protein concentration either of 2 to 10 nM (-0.1 pmol per reaction) (Fig. 2) or of 0.2 pM to 2 nM (Fig. 3) . In binding reactions, 20,000 to 50,000 cpm (-1 fmol) of -y-32P-labelled oligonucleotide was used for binding, and 1 ,ug (-1,000-fold excess over labelled probe by weight) of double-stranded poly(dI-dC) was present to compete for binding by nonspecific DNA binding proteins. In addition, in competition assays, 100 ng (4 pmol) of the following unlabelled doublestranded oligonucleotides was also included in the binding reactions lop; lopm; Xop, which is identical to 1/2 except that the three DMS-protected G. C base pairs shown above in the LexA operator binding site have been altered to the bases shown in boldface (ATATATATACATACAT); or NS, a blunt-ended 30-mer that carried a consensus palindromic thyroid response element (GGGGATCAGGTCATGACCTG GATCCTCTAG) (52) . Reactions were run on a 6% polyacrylamide gel (acryl-bis, 29:1 buffered in 0.25x TBE [1, 63] Table 1 . A number of the proteins (LexA-cFos, -Bicoid, -vMyc, and -cMyc) contain functional nuclear localization sequences (14, 27, 59, 73) , and at least the LexA-cFos and LexA-Myc fusion proteins are nuclear localized in mammalian cells (22) . Since the nuclear localization sequences of higher eukaryotes function in yeasts (53, 76) , we expect that the intranuclear concentrations of these proteins should be approximately 5-to 10-fold higher than if they were uniformly distributed throughout the cell. We thus estimated that nuclear concentrations of the fusion proteins ranged from 0.02 x 10-6 to 2.8 x 10-6 M for proteins expressed from CEN ARS plasmids (low concentrations) to 0.7 x 10-6 to 9.0 x 10-6 M for proteins expressed from 2pm plasmids (high concentrations).
When expressed at low concentrations, all five LexA derivatives activated transcription poorly or not at all (Table  1 ). In contrast, at higher concentrations, all five proteins activated transcription, some more strongly than others. For example, LexA1l87-cFos does not activate strongly at the lower concentration but does activate strongly at the higher concentration (Table 1) . We do not know whether the activation observed at the higher concentrations reflects operator saturation, but we conclude from this result that at the lower concentrations operators are predominantly unoccupied. On the basis of the inferred nuclear concentrations, this suggests that LexA 9, 13, and 17) . None of the specific bands observed competed with single-stranded specific lop competitor (not shown).
the reporter gene should give a relative measure of the site occupancy by LexA and LexAl-7-GAL4. We found that activation of the 2ops reporter by LexAl-7-GAL4 was completely blocked (<1 U) in the presence of native LexA, whereas in the absence of native LexA, the same reporter gene was activated by LexA1,7-GALA to high levels (>1,000 U) (Table 1) . Thus, even though LexAl87-GAIA was expressed in substantial excess over LexA, LexA completely inhibited its ability to activate transcription. We interpret these results to mean that native LexA bound the operators with a far greater affinity than did LexA1l7-GAL4.
Many LexA derivatives bind operators with low affinity in vitro. The experiments described above strongly suggested that LexA derivatives bound operator sites in vivo less well than did native LexA. This decrease in binding could indicate that LexA derivatives bound operators with lower affinity or that they were prevented from interacting with operators because they were sequestered by an interaction with some other cellular component (see Discussion). To distinguish between these ideas, we examined operator binding in vitro with a gel mobility shift assay (18, 19) by using whole cell extracts of yeast expressing different LexA derivatives. From Western blots, we estimated the concentration of LexA derivatives in these extracts to be at 2 x 10-9 to 10 x 10-9 M (not shown). A 36-bp double-stranded oligonucleotide that contained the lop site was used to assay binding. Under these conditions native LexA bound 50% of the lop site at a monomer concentration of -2 x 10-9 M (Fig. 2) and bound detectable quantities of operator at a VOL. 12, 1992 concentration of -2 x 10-11 M (Fig. 3) . This affinity is in good agreement with previously reported values determined for purified LexA protein in DNase I protection experiments in vitro (4, 15) .
In vitro, most LexA derivatives tested, including
LexAl-202-PRD, LexAl-202-PRD/HD, and LexAl202-vMyc AC (Fig. 2) , and LexA187-GALA and LexAl202-vMyc (not shown), did not give specific complexes with operator. LexA1l87 derivatives fell into two classes. Class 1 proteins (LexA1_87-Bicoid, LexA1l87-vMyc, and LexA1l7-cMyc) activated all the reporters poorly and are discussed below.
Class 2 proteins (LexAl187-GALA, LexAl-87-GCN4, and LexA1l87-cFos) did not activate the 1/2op reporter (with one exception) and activated the lopm reporter only weakly. They activated the lop reporter strongly and the 2op reporter only slightly more strongly. The exceptional class 2 protein, LexA1_87-GAL4, activated the 1/2op reporter extremely weakly but reproducibly (Table 3 and Discussion).
All LexA1l202 derivatives fell into class 3. None of these proteins activated the lI2op reporter. These proteins activated the lopm and lop reporters moderately strongly and to comparable levels. Some class 3 proteins (LexA1l202-B6, LexA1l202-Bicoid, LexA1_202-B7, and LexA1l202-vMyc) activated the 2op reporter substantially more strongly than the lop, while others (LexAl1202-B42 and LexAl-202vMAC) did not; probably because expression of ,B-galactosidase directed by the latter proteins from the lop reporter was already saturated (1,200 to 1,500 U [21, 25] ).
We then compared binding by native LexA to two of these sites in vitro (Fig. 3) . Measured by 1/2 maximal operator binding, under our conditions the affinity of LexA for the lopm site differed only slightly from its affinity for the lop site. In competition assays, the lopm site was 5-to 10-fold less effective as a competitor than the lop site. However, by either assay, this mutation in the lopm site does not severely impair operator binding. Taken with our in vivo data, these results show that binding by LexA and LexA derivatives containing the LexA88-202 domain is relatively insensitive to a weak operator mutation while binding by derivatives lacking this domain is significantly affected.
DISCUSSION
Operator binding by most LexA derivatives is impaired. Using transcription activation in yeast to monitor DNA binding in vivo and gel mobility shift assays to measure DNA binding in vitro, we found that operator binding by most LexA1-87 and LexA1l202 fusion proteins we examined is impaired relative to that of native LexA. This assertion is based on the following observations. First, fusion proteins that activated strongly when expressed at high levels did not activate (or did so very poorly) when expressed at lower concentrations, despite the fact that the estimated lower nuclear concentrations were as much as 2 to 3 orders of magnitude higher than the operator binding Kd for native LexA. Thus, at the lower concentrations, even though present in excess, the fusion proteins did not saturate their operator sites. Second, an in vivo competition experiment showed that LexA1_87-GAL4, even when expressed at a 10-fold excess over native LexA, did not compete efficiently with native LexA for operator binding. Third, in vitro binding assays failed to detect binding to operator-containing oligonucleotides for many fusion proteins, including fusions to both LexA1l7 and LexA1l202, under conditions in which native LexA bound avidly.
Relative to binding of native LexA, even binding by most LexA1l202 derivatives examined was substantially impaired (Table 3 and Fig. 2 ). It is worth noting, however, that two of the fused moieties we examined-vMyc and Bicoid-activated more strongly when they were fused to LexA1l202 than to LexA1l87 (Table 3) ; as we and others have argued, such differences in activation most likely result from improved operator occupancy conferred by the LexA88202 domain (33, 60) (see below). (Table 3) , we compared operator binding by LexA derivatives in which a homodimerization motif was provided by native LexA sequences (LexAj_202 fusions), was provided only by a heterologous moiety (for instance, LexAl-87-GCN4 [29] and LexAl-87-GAL4 [10] ), or in which no strong dimerization motif was present (e.g., LexAl87-vMyc and LexAl-87-cFos [55] [see below]). We assayed operator binding by examining activation by LexA derivatives of reporters that contained different operator variants. We reasoned that if the second view of operator binding described above was true, then in fusions that contain LexA88202 the energy gained from geometrically favorable monomer-monomer contacts between LexA88202 moieties might compensate for the energy lost from removal of a monomer-DNA contact; this might be revealed experimentally by an improved ability to interact with an operator with a weak mutation (lopm). Our results supported this second interpretation. All fusion proteins that contained the LexA88202 domain (class 3) activated the lopm and lop reporters similarly. In contrast, all fusion proteins that lacked the LexA88202 domain (class 2) were extremely sensitive to the lopm point mutation (10-to 20-fold differences in activation), whether they contained other dimerization motifs or not. While this result does not exclude the possibility that heterologous dimerization motifs not examined in this study may in fact substitute for the LexA88202 domain, clearly not all do so.
These experiments also raise a related point. Heretofore, strong activation by LexA_87 fusion proteins has been taken to imply that the fused moiety contains dimerization sequences. However, the above experiments strongly suggest that all dimerization sequences are not equivalent in promoting operator recognition. Moreover, a survey of the published literature on LexA-activator chimeras indicates that such proteins may not need to contain any dimerization sequences, LexA specific or not, in order to activate. A large number of LexAl87 derivatives activate; at least some of the fused moieties present are either thought to contain weak dimerization sequences or are not known to contain them at all (22, 24, 27, 36, 56) . Since it is unlikely that such proteins can quantitatively occupy operators, their abilities to activate may reflect the extreme sensitivity of the typical transcription activation assays, rather than their possession of dimerization sequences.
We note that although the LexA amino terminus has been shown to bind to isolated half-sites in vitro (37) [12, 44] (48) . In addition, the idea that LexA monomers can associate on the DNA has recently received independent biochemical support (37) .
Fusion domain-dependent interference with activation. We can imagine a number of possible mechanisms by which fusion domains might reduce activation by LexA1l7 derivatives. Any or all of these may be reflected in the extremely low activation observed with class 1 proteins. First, the fused sequences might interfere with proper folding of the LexA moiety. We regard this possibility as unlikely, but in the absence of structural data we cannot exclude it.
Second, if the LexA derivative contains a second DNAbinding domain, the protein might be sequestered from LexA operators by binding to nonoperator DNA; such sequestration would be most severe in cells that had complex genomes. Sequestration on the DNA may well explain why the DNA binding region of the v-rel product inhibits activation by LexA-vRel derivatives in mammalian cells but not in yeast cells (33, 57) , may account for lack of activation or inhibition of activation reported for the DNA binding domains of the Pit-1 (30) and Myc (22, 35) proteins, and may complicate the interpretation of studies of LexA-HMG derivatives, which also bind nonspecific DNA and which are reported not to activate at all (40) .
Third, an oligomerization motif in the fusion moiety might cause the LexA derivative to form a complex with other cellular proteins that either keeps it from binding operator or allows it to bind operator but occludes the activation domain. Such complex formation might explain why, for LexA-Myc and LexA-Fos fusion proteins, removal of the oligomerization motifs (the helix-loop-helix/leucine zipper and leucine zipper, respectively) results in a 5-to 10-fold increase in their abilities to activate (Table 3) (22, 35, 42) .
Fourth, the fusion moiety might sterically inhibit or otherwise increase the amount of energy required to position the LexA DNA binding domains properly on adjacent halfsites. Our in vitro data indicate that those fusion proteins least impaired for operator binding were those that contained relatively small fusion domains-the acid blobs B42, B6 (Fig. 3) , and B7 (not shown) and the small moiety encoded by the polylinker of pLexA1_202-PL. This last result raises the possibility that their relatively tighter binding contributes to the potency of acid blobs in transcription activation assays (50 LexA1-87-cFos [ Table 3 ]), activators should be compared on a reporter that carries a small number of operators, which should ideally be positioned far enough (>200 bp) upstream of the lacZ gene to ensure that transcription is well below the maximum level.
Third, one of the more important applications of chimeric proteins in yeasts is as transcriptionally inert baits to detect interacting proteins from activation domain-tagged cDNA expression libraries (13, 17, 23, 70, 71, 80) . Our data show that, at least when LexA derivatives are used for baits, two needs must be balanced. On one hand, many baits activate weakly, and it is important to saturate operator binding so that adventitious increases in bait expression in individual cells (21) cannot cause spurious activation of the reporter gene during the expression library screen. On the other hand, transcription of the reporter in a particular cell is dependent on the total amount of operator-bound bait that interacts with the activation domain-tagged protein encoded by a member of the expression library; for this to be maximized, the total concentration of bait should not exceed the total concentration of library-encoded protein. Our results suggest that these needs may be best met by the choice of LexAl-202 rather than LexAl-7 as a DNA binding domain and the use of short, nonactivating heterologous moieties in the bait. In addition, since native LexA lacks a nuclear localization sequence, gains in the degree of operator binding at low bait concentrations might come from the addition of a nuclear localization motif to baits.
Finally, although this study has confined itself to LexA derivatives, it is equally likely that some heterologous moieties can affect DNA recognition by other binding domains such as GAL4 (11) . Given that the structures of GAL4 and LexA are quite different (2, 38, 39, 51) 
